These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22335076)

  • 1. [Rare diseases: an "exceptional field of research. Interview by Catherine Holué].
    Dolfus H; Lévy N
    Rev Prat; 2012 Jan; 62(1):89-90. PubMed ID: 22335076
    [No Abstract]   [Full Text] [Related]  

  • 2. [GPs: patients require you to doubt! Interview by Catherine Holué].
    Viollet V
    Rev Prat; 2012 Jan; 62(1):85-6. PubMed ID: 22335075
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rare diseases: "a public health priorty". Interview by Catherine Holué].
    Podeur A
    Rev Prat; 2012 Jan; 62(1):79-80. PubMed ID: 22335073
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neuromuscular diseases are many but rare].
    Lindvall B
    Lakartidningen; 2013 Apr 10-16; 110(15):752-3. PubMed ID: 23662534
    [No Abstract]   [Full Text] [Related]  

  • 5. [Health technology assessment in the field of rare diseases at Haute Autorité de Santé in France].
    Bélorgey C
    Med Sci (Paris); 2018 May; 34 Hors série n°1():49-50. PubMed ID: 29911564
    [No Abstract]   [Full Text] [Related]  

  • 6. [Documentary research and self-instruction. Critical reading of a medical article. Practice guidelines. Part 1: rare diseases].
    Cordier JF; Aymé S
    Rev Prat; 2004 Apr; 54(7):777-9. PubMed ID: 15253297
    [No Abstract]   [Full Text] [Related]  

  • 7. Rare pulmonary diseases: a common fight.
    Harari S; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The stakes of pre- and post-market authorization development and clinical assessment].
    Schwebig A
    Presse Med; 2012 May; 41 Suppl 1():S6-8. PubMed ID: 22483770
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rare diseases are not orphan any longer].
    Cordier JF
    Rev Prat; 2012 Jan; 62(1):3. PubMed ID: 22335057
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network.
    Shimizu R; Ogata K; Tamaura A; Kimura E; Ohata M; Takeshita E; Nakamura H; Takeda S; Komaki H
    BMC Health Serv Res; 2016 Jul; 16():241. PubMed ID: 27401940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rare diseases in Lebanon: diagnostic difficulties and therapy].
    Mansour H
    Arch Pediatr; 2015 May; 22(5 Suppl 1):1-2. PubMed ID: 26112493
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient's perspective about research landscape for rare diseases in India.
    Kapadia A
    J Biosci; 2024; 49():. PubMed ID: 38383970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rare diseases, definitions and epidemiology].
    Donnart A; Viollet V; Roinet-Tournay M
    Soins Pediatr Pueric; 2013; (274):14-6. PubMed ID: 24228328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare-disease project has global ambitions.
    Abbott A
    Nature; 2011 Apr; 472(7341):17. PubMed ID: 21475168
    [No Abstract]   [Full Text] [Related]  

  • 15. Rare diseases: what's next?
    Remuzzi G; Garattini S
    Lancet; 2008 Jun; 371(9629):1978-9. PubMed ID: 18555899
    [No Abstract]   [Full Text] [Related]  

  • 16. Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy.
    Straub V; Balabanov P; Bushby K; Ensini M; Goemans N; De Luca A; Pereda A; Hemmings R; Campion G; Kaye E; Arechavala-Gomeza V; Goyenvalle A; Niks E; Veldhuizen O; Furlong P; Stoyanova-Beninska V; Wood MJ; Johnson A; Mercuri E; Muntoni F; Sepodes B; Haas M; Vroom E; Aartsma-Rus A
    Lancet Neurol; 2016 Jul; 15(8):882-890. PubMed ID: 27302365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European Union Policy in the Field of Rare Diseases.
    Moliner AM; Waligora J
    Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for eteplirsen: Paving the way for precision medicine.
    Miceli MC; Nelson SF
    Mol Genet Metab; 2016 Jun; 118(2):70-1. PubMed ID: 27102846
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current views on rare diseases research and orphan drugs development].
    Jiang J; Li J; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):724-9. PubMed ID: 21845839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The RARE 2017 meeting and the French Foundation of Rare Diseases].
    Mandel JL
    Med Sci (Paris); 2018 May; 34 Hors série n°1():8. PubMed ID: 29911543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.